# A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers

> **NCT02196805** · NA · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 120 (estimated)

## Conditions studied

- Chinese Healthy Volunteers

## Interventions

- **DRUG:** Group A: imported Probucol ( Lorelco)
- **DRUG:** Group B: Marketed Probucol ( Chang Tai)

## Key facts

- **NCT ID:** NCT02196805
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-09
- **Final completion:** 2009-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02196805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02196805, "A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02196805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*